194 related articles for article (PubMed ID: 26138584)
1. Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.
Yang C; Fischer-Kešo R; Schlechter T; Ströbel P; Marx A; Hofmann I
Tumour Biol; 2015 Dec; 36(12):9567-77. PubMed ID: 26138584
[TBL] [Abstract][Full Text] [Related]
2. Plakophilin-associated RNA-binding proteins in prostate cancer and their implications in tumor progression and metastasis.
Yang C; Ströbel P; Marx A; Hofmann I
Virchows Arch; 2013 Sep; 463(3):379-90. PubMed ID: 23881279
[TBL] [Abstract][Full Text] [Related]
3. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.
Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F
J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946
[TBL] [Abstract][Full Text] [Related]
4. SPOCK1 promotes tumor growth and metastasis in human prostate cancer.
Chen Q; Yao YT; Xu H; Chen YB; Gu M; Cai ZK; Wang Z
Drug Des Devel Ther; 2016; 10():2311-21. PubMed ID: 27486308
[TBL] [Abstract][Full Text] [Related]
5. Plakophilin 1 deficiency in prostatic tumours is correlated with immune cell recruitment and controls the up-regulation of cytokine expression post-transcriptionally.
Kim M; Reidenbach S; Schlechter T; Rothmann AC; Will R; Hofmann I
FEBS J; 2023 Apr; 290(7):1907-1919. PubMed ID: 36380691
[TBL] [Abstract][Full Text] [Related]
6. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
7. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
[TBL] [Abstract][Full Text] [Related]
8. Dual strands of pre-miR‑150 (miR‑150‑5p and miR‑150‑3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer.
Okato A; Arai T; Kojima S; Koshizuka K; Osako Y; Idichi T; Kurozumi A; Goto Y; Kato M; Naya Y; Ichikawa T; Seki N
Int J Oncol; 2017 Jul; 51(1):245-256. PubMed ID: 28534948
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of several fibulin genes in prostate cancer.
Wlazlinski A; Engers R; Hoffmann MJ; Hader C; Jung V; Müller M; Schulz WA
Prostate; 2007 Dec; 67(16):1770-80. PubMed ID: 17929269
[TBL] [Abstract][Full Text] [Related]
10. SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways.
Yang J; Yang Q; Yu J; Li X; Yu S; Zhang X
Oncol Rep; 2016 Jun; 35(6):3566-76. PubMed ID: 27108836
[TBL] [Abstract][Full Text] [Related]
11. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition.
Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845
[TBL] [Abstract][Full Text] [Related]
12. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
13. High SPOCK1 Expression is Associated with Advanced Stage, T Value, and Gleason Grade in Prostate Cancer.
Chen ML; Ho CJ; Yeh CM; Chen SL; Sung WW; Wang SC; Chen CJ
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31284511
[TBL] [Abstract][Full Text] [Related]
14. Plakophilin 1 is methylated and has a tumor suppressive activity in human lung cancer.
Haase D; Cui T; Yang L; Ma Y; Liu H; Theis B; Petersen I; Chen Y
Exp Mol Pathol; 2019 Jun; 108():73-79. PubMed ID: 30946843
[TBL] [Abstract][Full Text] [Related]
15. SPOCK1 promotes the proliferation and migration of colon cancer cells by regulating the NF-κB pathway and inducing EMT.
Liu HX; Cao YY; Qu JY
Neoplasma; 2021 Jul; 68(4):702-710. PubMed ID: 33884883
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
[TBL] [Abstract][Full Text] [Related]
17. Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression.
Breuninger S; Reidenbach S; Sauer CG; Ströbel P; Pfitzenmaier J; Trojan L; Hofmann I
Am J Pathol; 2010 May; 176(5):2509-19. PubMed ID: 20348237
[TBL] [Abstract][Full Text] [Related]
18. SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer.
Váncza L; Horváth A; Seungyeon L; Rókusz A; Dezső K; Reszegi A; Petővári G; Götte M; Kovalszky I; Baghy K
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046698
[TBL] [Abstract][Full Text] [Related]
19. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Wang HZ; Wang F; Chen PF; Zhang M; Yu MX; Wang HL; Zhao Q; Liu J
Biomed Pharmacother; 2019 Mar; 111():1234-1242. PubMed ID: 30841437
[TBL] [Abstract][Full Text] [Related]
20. MiR-129-5p influences the progression of gastric cancer cells through interacting with SPOCK1.
Yan L; Sun K; Liu Y; Liang J; Cai K; Gui J
Tumour Biol; 2017 Jun; 39(6):1010428317706916. PubMed ID: 28653880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
